1. A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation. Issue 12 (30th October 2018) Authors: Castroviejo‐Bermejo, Marta; Cruz, Cristina; Llop‐Guevara, Alba; Gutiérrez‐Enríquez, Sara; Ducy, Mandy; Ibrahim, Yasir Hussein; Gris‐Oliver, Albert; Pellegrino, Benedetta; Bruna, Alejandra; Guzmán, Marta; Rodríguez, Olga; Grueso, Judit; Bonache, Sandra; Moles‐Fernández, Alejandro; Villacampa, Guil... Journal: EMBO molecular medicine Issue: Volume 10:Issue 12(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation. Issue 12 (30th October 2018) Authors: Castroviejo‐Bermejo, Marta; Cruz, Cristina; Llop‐Guevara, Alba; Gutiérrez‐Enríquez, Sara; Ducy, Mandy; Ibrahim, Yasir Hussein; Gris‐Oliver, Albert; Pellegrino, Benedetta; Bruna, Alejandra; Guzmán, Marta; Rodríguez, Olga; Grueso, Judit; Bonache, Sandra; Moles‐Fernández, Alejandro; Villacampa, Guil... Journal: EMBO molecular medicine Issue: Volume 10:Issue 12(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation. Issue 12 (30th October 2018) Authors: Castroviejo‐Bermejo, Marta; Cruz, Cristina; Llop‐Guevara, Alba; Gutiérrez‐Enríquez, Sara; Ducy, Mandy; Ibrahim, Yasir Hussein; Gris‐Oliver, Albert; Pellegrino, Benedetta; Bruna, Alejandra; Guzmán, Marta; Rodríguez, Olga; Grueso, Judit; Bonache, Sandra; Moles‐Fernández, Alejandro; Villacampa, Guil... Journal: EMBO molecular medicine Issue: Volume 10:Issue 12(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Activity of HSP90 Inhibiton in a Metastatic Lung Cancer Patient With a Germline BRCA1 Mutation. (26th February 2018) Authors: Cedrés, Susana; Felip, Enriqueta; Cruz, Cristina; Martinez de Castro, Ana; Pardo, Nuria; Navarro, Alejandro; Martinez-Marti, Alex; Remon, Jordin; Zeron-Medina, Jorge; Balmaña, Judith; Llop-Guevara, Alba; Miquel, Josep M; Sansano, Irene; Nuciforo, Paolo; Mancuso, Francesco; Serra, Violeta; Vivanco... Journal: Journal of the National Cancer Institute Issue: Volume 110:Number 8(2018) Page Start: 914 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Anti‐tumoural activity of the G‐quadruplex ligand pyridostatin against BRCA1/2‐deficient tumours. Issue 3 (2nd February 2022) Authors: Groelly, Florian J; Porru, Manuela; Zimmer, Jutta; Benainous, Hugo; De Visser, Yanti; Kosova, Anastasiya A; Di Vito, Serena; Serra, Violeta; Ryan, Anderson; Leonetti, Carlo; Bruna, Alejandra; Biroccio, Annamaria; Tarsounas, Madalena Journal: EMBO molecular medicine Issue: Volume 14:Issue 3(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cancer network activity associated with therapeutic response and synergism. Issue 1 (December 2016) Authors: Serra-Musach, Jordi; Mateo, Francesca; Capdevila-Busquets, Eva; de Garibay, Gorka; Zhang, Xiaohu; Guha, Raj; Thomas, Craig; Grueso, Judit; Villanueva, Alberto; Jaeger, Samira; Heyn, Holger; Vizoso, Miguel; Pérez, Hector; Cordero, Alex; Gonzalez-Suarez, Eva; Esteller, Manel; Moreno-Bueno, Gema; Tj... Journal: Genome medicine Issue: Volume 8:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Controversies in oncology: are genomic tests quantifying homologous recombination repair deficiency (HRD) useful for treatment decision making?. Issue 2 (9th May 2019) Authors: Pellegrino, Benedetta; Mateo, Joaquin; Serra, Violeta; Balmaña, Judith Journal: ESMO open Issue: Volume 4:Issue 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. MiR‐182‐3p targets TRF2 and impairs tumor growth of triple‐negative breast cancer. Issue 1 (25th November 2022) Authors: Dinami, Roberto; Pompili, Luca; Petti, Eleonora; Porru, Manuela; D'Angelo, Carmen; Di Vito, Serena; Rizzo, Angela; Campani, Virginia; De Rosa, Giuseppe; Bruna, Alejandra; Serra, Violeta; Mano, Miguel; Giacca, Mauro; Leonetti, Carlo; Ciliberto, Gennaro; Tarsounas, Madalena; Stoppacciaro, Antonella... Journal: EMBO molecular medicine Issue: Volume 15:Issue 1(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Modulation of telomere protection by the PI3K/AKT pathway. Issue 1 (December 2017) Authors: Méndez-Pertuz, Marinela; Martínez, Paula; Blanco-Aparicio, Carmen; Gómez-Casero, Elena; Belen García, Ana; Martínez-Torrecuadrada, Jorge; Palafox, Marta; Cortés, Javier; Serra, Violeta; Pastor, Joaquin; Blasco, Maria Journal: Nature communications Issue: Volume 8:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Sensitizing HR-proficient cancers to PARP inhibitors. (2nd November 2017) Authors: Lim, Elgene; Johnson, Shawn F.; Geyer, Matthias; Serra, Violeta; Shapiro, Geoffrey I. Journal: Molecular & cellular oncology Issue: Volume 4:Number 6(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗